Carisma Therapeutics Inc. Files 8-K: Material Agreement
Ticker: CARM · Form: 8-K · Filed: Jun 23, 2025 · CIK: 1485003
Sentiment: neutral
Topics: material-agreement, filing, corporate-actions
TL;DR
CARisma Therapeutics signed a material definitive agreement, filing an 8-K. Big news pending.
AI Summary
On June 22, 2025, Carisma Therapeutics Inc. entered into a material definitive agreement. The filing also includes Regulation FD disclosures and financial statements. The company, formerly known as Sesen Bio, Inc. and Eleven Biotherapeutics, Inc., is incorporated in Delaware and headquartered in Philadelphia, PA.
Why It Matters
This filing indicates a significant development for Carisma Therapeutics Inc., potentially impacting its business operations and future financial performance.
Risk Assessment
Risk Level: medium — Material definitive agreements can introduce new risks or opportunities, and the specifics of this agreement are not detailed in the provided excerpt.
Key Players & Entities
- Carisma Therapeutics Inc. (company) — Registrant
- June 22, 2025 (date) — Earliest event reported
- Sesen Bio, Inc. (company) — Former company name
- Eleven Biotherapeutics, Inc. (company) — Former company name
- Delaware (jurisdiction) — State of incorporation
- Philadelphia, PA (location) — Company headquarters
FAQ
What is the nature of the material definitive agreement entered into by Carisma Therapeutics Inc. on June 22, 2025?
The provided excerpt does not specify the details of the material definitive agreement.
What are the key items reported in this 8-K filing?
The filing reports an entry into a material definitive agreement, Regulation FD disclosures, and financial statements and exhibits.
When was the earliest event reported in this filing?
The earliest event reported was on June 22, 2025.
What were Carisma Therapeutics Inc.'s former company names?
Carisma Therapeutics Inc. was formerly known as Sesen Bio, Inc. and Eleven Biotherapeutics, Inc.
Where is Carisma Therapeutics Inc. incorporated and headquartered?
Carisma Therapeutics Inc. is incorporated in Delaware and headquartered in Philadelphia, PA.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 23, 2025 regarding Carisma Therapeutics Inc. (CARM).